Testosterone levels increased by 223% with no significant difference between groups
Treatment of Hypoactive Sexual Desire Disorder (HSDD) in Women: PT-141 (Bremelanotide) is a melanocortin receptor agonist (MC3R/MC4R) that treats hypoactive sexual desire disorder (HSDD) in women by stimulating neural pathways in the central nervous system (1)
PMID: 33 JohnEMKooJPhippsAILongacreTAKurianAWInglesSAet al
Others experience more gradual benefitslike improved focus, smoother digestion, or resilienceover a series of treatments
When it runs low, the symptoms read like a tired, foggy, low-mood version of yourself which is why correcting it can feel so noticeable
Whether youre training, recovering from physical strain, or simply committed to moving well for lifeBPC-157 is designed to help support your daily health foundation